Monday, July 8, 2019

SPARC gets orphan drug designation from USFDA for novel kinase inhibitor

SPARC gets orphan drug designation from USFDA for novel kinase inhibitor The Orphan Drug Act provides economic incentives to encourage the development of drugs for diseases affecting fewer than 2 lakh people in the US, Sun Pharma Advanced Research Company (SPARC) said in a filing to BSE.

from Moneycontrol Business News https://ift.tt/2L8Hplf
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

German-Iranian national executed in Iran; long time US resident was 'Israeli spy,' says Tehran

The execution took place on Monday morning, as per state news agency IRNA, which described the 69-year-old as "Israeli-linked spy and s...